Dashboard
Manage Tickers

ANEBAnebulo Pharmaceuticals, Inc.

Nasdaq anebulo.com


$ 3.20 $ 0.16 (5.41 %)    

Thursday, 02-May-2024 10:05:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.62 $ 1.37 (0.32 %)
DIA $ 385.74 $ -1.02 (-0.26 %)
SPY $ 509.23 $ -1.30 (-0.25 %)
TLT $ 89.58 $ -0.53 (-0.59 %)
GLD $ 212.32 $ -1.10 (-0.52 %)
$ 3.12
$ 3.20
$ 0.00 x 0
$ 0.00 x 0
$ 3.20 - $ 3.20
$ 1.62 - $ 4.05
8,476
na
80.46M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 09-22-2023 06-30-2023 10-K
4 05-11-2023 03-31-2023 10-Q
5 02-10-2023 12-31-2022 10-Q
6 11-10-2022 09-30-2022 10-Q
7 09-09-2022 06-30-2022 10-K
8 05-11-2022 03-31-2022 10-Q
9 02-11-2022 12-31-2021 10-Q
10 11-12-2021 09-30-2021 10-Q
11 09-22-2021 06-30-2021 10-K
12 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

substance-use-disorder-company-narrows-q2-net-loss-reports-progress-on-cannabinoid-intoxication-drug
Substance Use Disorder Company Narrows Q2 ...
02/14/2024 16:37:40

Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday secon...

anebulo-pharmaceuticals-announces-richie-cunningham-as-chief-executive-officer
Anebulo Pharmaceuticals Announces Richie C...
02/13/2024 21:44:29

anebulo-pharmaceuticals-q2-eps-011-misses-010-estimate
Anebulo Pharmaceuticals Q2 EPS $(0.11) Mis...
02/13/2024 21:43:59

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimat...

anebulo-pharmaceuticals-filed-us-patent-application-20240010617-crystalline-forms-of-a-cannabinoid-receptor-type-1-cb1-modulator-and-methods-of-use-and-preparation-thereof
Anebulo Pharmaceuticals Filed U.S. Patent ...
01/11/2024 11:42:54

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240010617<p> Float: 3,912,399

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
12/21/2023 17:32:34

anebulo-pharmaceuticals-q1-eps-010-beats-012-estimate
Anebulo Pharmaceuticals Q1 EPS $(0.10) Bea...
11/14/2023 21:59:46

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate ...

why-servisfirst-bancshares-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why ServisFirst Bancshares Shares Are Trad...
10/17/2023 17:42:48

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
10/17/2023 17:31:01

anebulo-pharmaceuticals-incs-richie-cunningham-announced-as-chief-executive-officer-and-member-of-anebulos-board-of-directors
Anebulo Pharmaceuticals Inc's Richie Cunni...
10/06/2023 20:07:31

- Reuters

benchmark-reiterates-speculative-buy-on-anebulo-pharmaceuticals-maintains-8-price-target
Benchmark Reiterates Speculative Buy on An...
10/03/2023 15:52:05

Benchmark analyst Robert Wasserman reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Speculative Buy and maintains $8 ...

on-september-26-2023-anebulo-pharmaceuticals-appointed-daniel-george-as-the-companys-part-time-cfo-principal-financial-officer-and-principal-accounting-officer-effective-september-28-replacing-sandra-gardiner---8k
On September 26, 2023, Anebulo Pharmaceuti...
09/29/2023 11:23:41

https://www.sec.gov/ix?doc=/Archives/edgar/data/1815974/000149315223034696/form8-k.htm

hc-wainwright--co-reiterates-buy-on-anebulo-pharmaceuticals-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Aneb...
09/25/2023 10:10:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and maintains...

maxim-group-initiates-coverage-on-anebulo-pharmaceuticals-with-buy-rating-announces-price-target-of-6
Maxim Group Initiates Coverage On Anebulo ...
09/21/2023 15:49:45

Maxim Group analyst Michael Okunewitch initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and ann...

anebulo-pharmaceuticals-q4-eps-010-beats-012-estimate
Anebulo Pharmaceuticals Q4 EPS $(0.10) Bea...
09/20/2023 20:30:17

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate ...

substance-use-disorder-focused-anebulo-could-be-attractive-acquisition-target-analyst-says
Substance Use Disorder Focused Anebulo Cou...
09/18/2023 17:13:10

H.C.

benzingas-top-ratings-upgrades-downgrades-for-september-18-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/18/2023 15:00:36

hc-wainwright--co-initiates-coverage-on-anebulo-pharmaceuticals-with-buy-rating-announces-price-target-of-6
HC Wainwright & Co. Initiates Coverage On ...
09/18/2023 10:33:22

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy ra...

on-august-29-anebulo-pharmaceuticals-incs-sandra-a-gardiner-notified-company-of-her-resignation-as-cos-acting-cfo
On August 29, Anebulo Pharmaceuticals Inc'...
09/05/2023 12:09:55

- Reuters

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
08/22/2023 13:06:03

anebulo-receives-positive-feedback-from-fda-on-path-to-phase-3-trial-of-its-drug-for-acute-cannabinoid-intoxication
Anebulo Receives Positive Feedback From FD...
08/21/2023 13:23:06

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced positive feedback from the United States Food and Drug Administration fo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION